Endovascular treatment experience in acute ischemic stroke
Main Article Content
Abstract
Background and Objective: Thrombolytic and mechanical thrombectomy therapies are proven treatment methods in patients with acute stroke. Aim is to share our experience in acute stroke therapy with colleagues.
Material and methods: In this study we evaluated the patients who underwent MT or MT + IV-tPA between 2018-2019 retrospectively. Demographic features, comorbid diseases of patients, symptom onset-to-gate and symptom gate-to-puncture durations, mRS (Modified Rankin Score) and NIHSS (National Institutes of Health Stroke Scale) score, treatment method and degree of recanalization were listed.
Results: MT was applied to 29 patients, MT + bolus IV-tPA was applied to 12 patients and MT + full dose IV-tPA was applied to 7 patients. The mean age was 66 ± 15 years, arrival mRS was 2 ± 2, arrival NIHSS score was 14 ± 5, onset-to-gate duration was 185 minutes and gate-to-puncture duration was 118 minutes.
Conclusion: The rate of recanalization, functional independence and mortality were similar to the HERMES study. It was observed a higher rate of intracranial hemorrhage in patients who received bolus or full dose IV-Tpa compared to patients who underwent MT. These results have led us to question the necessity of giving bolus or full dose IV-tPA before MT. Onset-to-gate and gate-to-puncture durations were found longer than the recommended durations. Rapid and effective management of AIS patients will provide good clinical results.
Article Details
Copyright (c) 2021 Erdoğan HA, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, et-al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003; 34: e109-137. PubMed: https://pubmed.ncbi.nlm.nih.gov/12869717/
NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587. PubMed: https://pubmed.ncbi.nlm.nih.gov/7477192/
Hache W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al. ECASS investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-1329. PubMed: https://pubmed.ncbi.nlm.nih.gov/18815396/
Powers WJ, Derdeny CP, Biller J, Coffey CS, Hoh BL, et al. American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines fort he Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46: 3020-3035. PubMed: https://pubmed.ncbi.nlm.nih.gov/26123479/
Hacke W. A new DAWN for imaging-based selection in the treat- ment of acute stroke. N Engl J Med. 2018; 378: 81–83. PubMed: https://pubmed.ncbi.nlm.nih.gov/29129127/
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018; 378: 708–718. PubMed: https://pubmed.ncbi.nlm.nih.gov/29364767/
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 372: 1019-1030. PubMed: https://pubmed.ncbi.nlm.nih.gov/25671798/
Gory B, Eldesouky I, Sivan-Hoffmann R, Rabilloud M, Ong E, et al. Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review. J Neurol Neurosurg Psychiatry. 2016; 87: 520-525. PubMed: https://pubmed.ncbi.nlm.nih.gov/25986363/
Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009; 4: Cd000213. PubMed: https://pubmed.ncbi.nlm.nih.gov/25072528/
Azzimondi G, Bassein L, Fiorani L, Nonino F, Montaguti U, et al. Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. Stroke. 1997; 28: 537-542. PubMed: https://pubmed.ncbi.nlm.nih.gov/9056608/